DK1165115T3 - Modulering af vaskulær permeabilitet ved hjælp af TIE2-receptor aktivatorer - Google Patents
Modulering af vaskulær permeabilitet ved hjælp af TIE2-receptor aktivatorerInfo
- Publication number
- DK1165115T3 DK1165115T3 DK00916545T DK00916545T DK1165115T3 DK 1165115 T3 DK1165115 T3 DK 1165115T3 DK 00916545 T DK00916545 T DK 00916545T DK 00916545 T DK00916545 T DK 00916545T DK 1165115 T3 DK1165115 T3 DK 1165115T3
- Authority
- DK
- Denmark
- Prior art keywords
- vascular permeability
- modulation
- tie2 receptor
- receptor activators
- mammal
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1891—Angiogenesic factors; Angiogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12653999P | 1999-03-26 | 1999-03-26 | |
US09/286,033 US6455035B1 (en) | 1999-03-26 | 1999-04-05 | Angiopoietins and methods of use thereof |
PCT/US2000/007336 WO2000057901A1 (en) | 1999-03-26 | 2000-03-20 | Modulation of vascular permeability by means of tie2 receptor activators |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1165115T3 true DK1165115T3 (da) | 2003-09-22 |
Family
ID=26824785
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK00916545T DK1165115T3 (da) | 1999-03-26 | 2000-03-20 | Modulering af vaskulær permeabilitet ved hjælp af TIE2-receptor aktivatorer |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP1165115B1 (da) |
JP (1) | JP2002540165A (da) |
AT (1) | ATE241380T1 (da) |
AU (1) | AU769198B2 (da) |
CA (1) | CA2368670C (da) |
DE (1) | DE60003011T2 (da) |
DK (1) | DK1165115T3 (da) |
ES (1) | ES2199804T3 (da) |
HK (1) | HK1043537A1 (da) |
IL (2) | IL145504A0 (da) |
NO (1) | NO329198B1 (da) |
NZ (1) | NZ514434A (da) |
PT (1) | PT1165115E (da) |
WO (1) | WO2000057901A1 (da) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002022176A1 (en) | 2000-09-15 | 2002-03-21 | Genvec, Inc. | Method of modulating neovascularization |
AU2006228095B2 (en) * | 2001-10-11 | 2010-11-04 | Amgen Inc. | Angiopoietin-2 specific binding agents |
US7205275B2 (en) * | 2001-10-11 | 2007-04-17 | Amgen Inc. | Methods of treatment using specific binding agents of human angiopoietin-2 |
US7521053B2 (en) * | 2001-10-11 | 2009-04-21 | Amgen Inc. | Angiopoietin-2 specific binding agents |
US7138370B2 (en) * | 2001-10-11 | 2006-11-21 | Amgen Inc. | Specific binding agents of human angiopoietin-2 |
US7658924B2 (en) * | 2001-10-11 | 2010-02-09 | Amgen Inc. | Angiopoietin-2 specific binding agents |
MX2007004247A (es) * | 2004-10-19 | 2007-06-12 | Amgen Inc | Agentes de aglutinacion especifica a angiopoyetina-2. |
RU2394839C2 (ru) | 2004-12-21 | 2010-07-20 | Астразенека Аб | Антитела против ангиопоэтина-2 и их применение |
NZ569787A (en) * | 2005-12-15 | 2011-07-29 | Astrazeneca Ab | Combination of angiopoietin-2 antagonist and of VEGF-A, KDR and/or FLT1 antagonist for treating cancer |
MX2008012991A (es) | 2006-04-07 | 2008-10-17 | Procter & Gamble | Anticuerpos que ligan proteina tirosina fosfatasa humana beta (hptpbeta) y los usos de estos. |
US7622593B2 (en) | 2006-06-27 | 2009-11-24 | The Procter & Gamble Company | Human protein tyrosine phosphatase inhibitors and methods of use |
AU2009209251B8 (en) | 2008-01-28 | 2015-03-26 | Medimmune Limited | Stabilized Angiopoietin-2 antibodies and uses thereof |
JO2913B1 (en) | 2008-02-20 | 2015-09-15 | امجين إنك, | Antibodies directed towards angiopoietin-1 and angiopoietin-2 proteins and their uses |
TR201809280T4 (tr) * | 2009-01-12 | 2018-07-23 | Aerpio Therapeutics Inc | Vasküler sızıntı sendromunun tedavi edilmesine yönelik yöntemler. |
AU2016203254B2 (en) * | 2009-01-12 | 2018-09-13 | EyePoint Pharmaceuticals, Inc. | Methods for treating vascular leak syndrome |
PT2451279T (pt) | 2009-07-06 | 2019-06-18 | Aerpio Therapeutics Inc | Derivados de benzosulfonamida, composições dos mesmos, e uso dos mesmos na prevenção de metástases de células cancerígenas |
AU2012323856B2 (en) | 2011-10-13 | 2017-05-25 | EyePoint Pharmaceuticals, Inc. | Methods for treating Vascular Leak Syndrome and cancer |
CN104066448A (zh) | 2011-10-13 | 2014-09-24 | 阿尔皮奥治疗学股份有限公司 | 眼病的治疗 |
US20150050277A1 (en) | 2013-03-15 | 2015-02-19 | Aerpio Therapeutics Inc. | Compositions and methods for treating ocular diseases |
US9828422B2 (en) | 2013-07-29 | 2017-11-28 | Samsung Electronics Co., Ltd. | Anti-Ang2 antibody |
KR102196450B1 (ko) | 2013-09-17 | 2020-12-30 | 삼성전자주식회사 | Tie2와 결합을 유도하는 항 Ang2 항체를 포함하는 항암제 |
JP6483148B2 (ja) | 2014-03-14 | 2019-03-13 | エアーピオ セラピューティクス インコーポレイテッド | HPTP−β阻害剤 |
JP6959924B2 (ja) | 2015-09-23 | 2021-11-05 | エアーピオ ファーマシューティカルズ, インコーポレイテッド | Tie−2の活性化物質を用いる眼内圧を処置する方法 |
SG11201900464TA (en) | 2016-07-20 | 2019-02-27 | Aerpio Therapeutics Inc | HUMANIZED MONOCLONAL ANTIBODIES THAT TARGET VE-PTP (HPTP-ß) |
CA3138682A1 (en) | 2019-04-29 | 2020-11-05 | EyePoint Pharmaceuticals, Inc. | Tie-2 activators targeting the schlemm's canal |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6277318A (ja) * | 1985-10-01 | 1987-04-09 | Eisai Co Ltd | 熱傷治療剤 |
US5482930A (en) * | 1993-06-09 | 1996-01-09 | The Regents Of The University Of California | Anti-inflammatory composition and method with des-Tyr dynorphin and analogues |
ES2327440T3 (es) * | 1996-08-23 | 2009-10-29 | Vegenics Limited | Factor recombinante de crecimiento de las celulas endoteliales vasculares-d (vegf-d). |
US6365154B1 (en) * | 1998-09-28 | 2002-04-02 | Smithkline Beecham Corporation | Tie2 agonist antibodies |
-
2000
- 2000-03-20 WO PCT/US2000/007336 patent/WO2000057901A1/en active IP Right Grant
- 2000-03-20 EP EP00916545A patent/EP1165115B1/en not_active Expired - Lifetime
- 2000-03-20 IL IL14550400A patent/IL145504A0/xx active IP Right Grant
- 2000-03-20 ES ES00916545T patent/ES2199804T3/es not_active Expired - Lifetime
- 2000-03-20 DE DE60003011T patent/DE60003011T2/de not_active Expired - Lifetime
- 2000-03-20 JP JP2000607651A patent/JP2002540165A/ja active Pending
- 2000-03-20 PT PT00916545T patent/PT1165115E/pt unknown
- 2000-03-20 AU AU37634/00A patent/AU769198B2/en not_active Expired
- 2000-03-20 CA CA2368670A patent/CA2368670C/en not_active Expired - Lifetime
- 2000-03-20 NZ NZ514434A patent/NZ514434A/en not_active IP Right Cessation
- 2000-03-20 DK DK00916545T patent/DK1165115T3/da active
- 2000-03-20 AT AT00916545T patent/ATE241380T1/de active
-
2001
- 2001-09-17 IL IL145504A patent/IL145504A/en not_active IP Right Cessation
- 2001-09-26 NO NO20014673A patent/NO329198B1/no not_active IP Right Cessation
-
2002
- 2002-05-15 HK HK02103669.2A patent/HK1043537A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
WO2000057901A1 (en) | 2000-10-05 |
IL145504A0 (en) | 2002-06-30 |
NO20014673L (no) | 2001-11-22 |
NO329198B1 (no) | 2010-09-13 |
AU3763400A (en) | 2000-10-16 |
DE60003011D1 (de) | 2003-07-03 |
JP2002540165A (ja) | 2002-11-26 |
ES2199804T3 (es) | 2004-03-01 |
IL145504A (en) | 2008-08-07 |
HK1043537A1 (zh) | 2002-09-20 |
CA2368670C (en) | 2012-06-05 |
DE60003011T2 (de) | 2004-04-08 |
CA2368670A1 (en) | 2000-10-05 |
PT1165115E (pt) | 2003-10-31 |
NO20014673D0 (no) | 2001-09-26 |
AU769198B2 (en) | 2004-01-22 |
ATE241380T1 (de) | 2003-06-15 |
EP1165115B1 (en) | 2003-05-28 |
NZ514434A (en) | 2003-11-28 |
EP1165115A1 (en) | 2002-01-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1165115T3 (da) | Modulering af vaskulær permeabilitet ved hjælp af TIE2-receptor aktivatorer | |
DE59911670D1 (de) | Glutamin-Thiazolidide und -Pyrrolidide sowie ihre Verwendung als Dipeptidylpeptidase IV Inhibitoren | |
TR200000782T2 (tr) | Resorsinol türevleri. | |
DK1187632T3 (da) | Behandling med anti-ErbB2-antistoffer | |
BR0108396A (pt) | Derivados de pirimidina-4-0na como inibidores de ldl-pla(2) | |
ID19242A (id) | Pirometer untuk gas dapur api | |
DK1109571T3 (da) | Fremgangsmåde til behandling af saltafhængig hypertension | |
ATE274348T1 (de) | Überbrückte indenopyrrolocarbazole | |
ATE382060T1 (de) | Moleküle und verfahren zur inhibierung der freisetzung von kim-1 | |
DK1411916T3 (da) | Fremgangsmåder og materialer til behandling af testosteronmangel hos mænd | |
EA200000519A1 (ru) | 2-АРИЛБЕНЗО[b]ТИОФЕНЫ, ПОЛЕЗНЫЕ ДЛЯ ЛЕЧЕНИЯ СИНДРОМА ЭСТРОГЕННОЙ НЕДОСТАТОЧНОСТИ | |
TR200001290T2 (tr) | Estrojen mahrumiyet sendromunu tedavi etmek için yararlı 2-aril-3-aroilbenzo(b) tiofenler. | |
TR200103125T2 (tr) | Otizmin iyileştirilmesinde kullanıma yönelik antikonvülsan türevleri. | |
AR026901A1 (es) | Peptidos con n-alquilacion que tienen actividad antiangiogenica | |
ATE315782T1 (de) | Karl-fischer-reagenz | |
BR0114884A (pt) | Compostos calcilìticos | |
DE50003452D1 (de) | Wässrige zusammensetzung zur filzfreiausrüstung von wolle | |
DE50109698D1 (de) | N-heteroarylmethyl-m-phenylendiamin-derivate enthaltende färbemittel für keratinfasern sowie neue n-heteroarylmethyl-m-phenylendiamin-derivate | |
PT1156999E (pt) | Metodo para a preparacao de um beta-aminoester quiral | |
DE69631500D1 (de) | Inhibitor des Hepatozytwachstumsfaktoraktivators | |
ATE270113T1 (de) | Zusammenstellungen zur verbesserten wundheilung | |
NZ331678A (en) | Method of checking integrity of modified atmosphere package by placing gas indicator between package and liner | |
DE50010740D1 (de) | Färbemittel und verwendung | |
UA32223A (uk) | Сонцезахисні окуляри | |
ITMI991903A0 (it) | Pistola sparalamelle e/o groppini particolarmente utilizata per cornic i e simili |